Analyst Recommendations

Outperform Recommendation Issued On DRI By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for DRI on March 18, 2024 07:57AM ET. The previous analyst recommendation was Outperform.DRI was trading at $173.015 at issue of the analyst...

March 18, 2024   DRI 1.02%

Outperform Recommendation Issued On DRI By Wedbush
Wedbush analyst issues OUTPERFORM recommendation for DRI on March 18, 2024 07:57AM ET. The previous analyst recommendation was Outperform.DRI was trading at $173.015 at issue of the analyst...

March 18, 2024   DRI 1.02%

Overweight Recommendation Issued On MU By Cantor Fitzgerald
Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for MU on March 18, 2024 07:52AM ET. The previous analyst recommendation was Overweight.MU was trading at $95.6491 at issue of the...

March 18, 2024   MU 2.96%

Buy Recommendation Issued On NVDA By HSBC
HSBC analyst issues BUY recommendation for NVDA on March 18, 2024 07:52AM ET. The previous analyst recommendation was Buy.NVDA was trading at $914.207 at issue of the analyst...

March 18, 2024   NVDA 1.85%

Buy Recommendation Issued On DT By Wolfe Research
Wolfe Research analyst issues BUY recommendation for DT on March 18, 2024 08:00AM ET. The previous analyst recommendation was Buy.DT was trading at $46.225 at issue of the...

March 18, 2024   DT -0.03%

Underperform Recommendation Issued On ROE By William Blair
William Blair analyst issues UNDERPERFORM recommendation for ROE on March 18, 2024 08:00AM ET. The previous analyst recommendation was Underperform.ROE was trading at $0 at issue of the...

March 18, 2024   ROE 1.20%

Overweight Recommendation Issued On APPF By Stephens
Stephens analyst issues OVERWEIGHT recommendation for APPF on March 18, 2024 08:01AM ET. The previous analyst recommendation was Overweight.APPF was trading at $224.44 at issue of the analyst...

March 18, 2024   APPF -0.43%

Outperform Recommendation Issued On CHTR By Bernstein
Bernstein analyst issues OUTPERFORM recommendation for CHTR on March 18, 2024 06:14AM ET. CHTR was trading at $290.65 at issue of the analyst recommendation.The overall analyst consensus :...

March 18, 2024   CHTR -0.21%

Buy Recommendation Issued On GMED By BTIG
BTIG analyst issues BUY recommendation for GMED on March 18, 2024 05:54AM ET. GMED was trading at $51.4 at issue of the analyst recommendation.The overall analyst consensus :...

March 18, 2024   GMED 0.71%

Market Perform Recommendation Issued On EQR By Raymond James
Raymond James analyst issues MARKET PERFORM recommendation for EQR on March 18, 2024 03:49AM ET. EQR was trading at $63.03 at issue of the analyst recommendation.The overall analyst...

March 18, 2024   EQR 0.97%